Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer
Clinical trial NCT01231581 · COMPLETED
Trial details
- NCT number
- NCT01231581
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.